Votrient and Pulmonary hypertension secondary - from FDA reports

There is no Pulmonary hypertension secondary reported by people who take Votrient yet. This review analyzes which people have Pulmonary hypertension secondary with Votrient. It is created by eHealthMe based on reports from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).

On Oct, 22, 2018

No report is found.

Do you have Pulmonary hypertension secondary while taking Votrient?

You are not alone:

Related studies


Votrient has active ingredients of pazopanib hydrochloride. It is often used in metastatic renal cell carcinoma. (latest outcomes from Votrient 16,328 users)

Pulmonary Hypertension Secondary

Pulmonary hypertension secondary (increase in blood pressure in the lung artery) has been reported by people with pulmonary hypertension secondary, pulmonary hypertension primary, herpes zoster, peripheral vascular disorder, migraine with aura (latest reports from 548 Pulmonary hypertension secondary patients).

Drugs that are associated with Pulmonary hypertension secondary
Pulmonary hypertension secondary
Could your condition cause Pulmonary hypertension secondary
Pulmonary hypertension secondary
Votrient side effects
Browse all side effects of Votrient
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Votrient and have Pulmonary hypertension secondary

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.